{
    "clinical_study": {
        "@rank": "141362", 
        "arm_group": [
            {
                "arm_group_label": "Cognitive behavioral therapy (CBT) alone", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Cognitive behavioral therapy plus HRV biofeedback", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The aims of this study are: 1) to estimate the effect size of HRV biofeedback for stress in\n      adolescents undergoing cognitive behavioral therapy (CBT) for cannabis use disorder (primary\n      outcome: Perceived Stress Scale) and 2) to estimate the effect size of HRV biofeedback for\n      cannabis use in adolescents undergoing CBT for cannabis use disorder (primary outcome:\n      number of days used cannabis in the past 30 days)."
        }, 
        "brief_title": "Biofeedback for Adolescent Cannabis Use Disorder", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Adolescent Cannabis Use Disorder", 
        "condition_browse": {
            "mesh_term": "Marijuana Abuse"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  be between the ages of 13 and 19 years, with a parent or legal guardian available to\n             complete parental assessments, if the participant is a minor\n\n          -  meet Diagnostic and Statistical Manual of Mental Disorders, 5th edition, (DSM-V)\n             criteria for cannabis use disorder by clinical interview;\n\n          -  be medically healthy;\n\n          -  be willing to participate in the study intervention and assessments;\n\n          -  plan to live locally for at least 4 months;\n\n          -  be able to read English well enough to complete study questionnaires;\n\n          -  have self-reported cannabis use in the past 28 days;\n\n          -  have a Perceived Stress Scale score > 20.\n\n        Exclusion Criteria:\n\n          -  current or past psychosis;\n\n          -  bipolar I or II disorder;\n\n          -  the need to take psychotropic medications at any time during the study;\n\n          -  pregnancy;\n\n          -  psychiatric or substance use disorder that cannot be managed with outpatient care\n             (e.g. alcohol withdrawal, severe major depressive disorder, significant suicidal\n             ideation); and\n\n          -  medications known to affect HRV (e.g. albuterol, pseudoephedrine, beta adrenergic\n             blockers)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "19 Years", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02059083", 
            "org_study_id": "13-0412"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cognitive behavioral therapy plus HRV biofeedback", 
                "intervention_name": "Heart rate variability biofeedback", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Cognitive behavioral therapy (CBT) alone", 
                "intervention_name": "CBT", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "adolescent", 
            "cannabis", 
            "biofeedback"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "number_of_arms": "2", 
        "official_title": "Biofeedback for Adolescent Cannabis Use Disorder", 
        "overall_contact": {
            "email": "christian.thurstone@dhha.org", 
            "last_name": "Christian Thurstone, M.D.", 
            "phone": "303-602-1896"
        }, 
        "overall_official": {
            "affiliation": "Denver Health", 
            "last_name": "Christian Thurstone, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Perceived Stress Scale", 
            "safety_issue": "No", 
            "time_frame": "baseline and 16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02059083"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Change in the number of days used marijuana in the past 28 days", 
            "safety_issue": "No", 
            "time_frame": "baseline and 16 weeks"
        }, 
        "source": "Denver Health and Hospital Authority", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Denver Health and Hospital Authority", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}